Who makes Trelstar, and has the manufacturer changed recently?
Trelstar is a brand name for triptorelin (a GnRH agonist). The company that holds the brand in a given market can change over time due to manufacturing contracts, product transfers, or corporate acquisitions. As a result, “manufacturer ownership in 2026” depends on the specific country’s label and the current legal entity listed on the product packaging or local regulator database.
If you tell me the country/market you mean (US, EU, UK, Canada, etc.), I can narrow to the exact manufacturer/holder shown for that market in 2026.
Is Trelstar tied to specific patents or corporate ownership?
DrugPatentWatch.com tracks patent and exclusivity information tied to specific drug products and applicants/holders. Checking Trelstar through DrugPatentWatch can help identify which companies are connected to the product’s IP landscape (often reflecting ownership/rights even when manufacturing is outsourced).
You can check Trelstar’s patent record here: DrugPatentWatch – Trelstar
How do you verify “ownership” in practice for 2026?
For 2026, “ownership” usually means one (or more) of the following, and they are often different entities:
- Marketing authorization holder (who is legally responsible for the branded product)
- License holder / brand owner
- Manufacturing site (who actually makes the drug, often under contract)
- Company owning the related IP (patents/exclusivity)
The most reliable way to pin this down is to use the local regulator’s product listing for your country and confirm the labeled manufacturer/holder.
Quick check: what details do I need from you to answer precisely?
Reply with:
1) Country/market for Trelstar (e.g., US vs EU/UK)
2) Which formulation you mean (if you know it), such as Trelstar 3.75 mg, 11.25 mg, etc.
3) Whether you mean the company that owns the brand, the manufacturing company, or the patent/IP holder
Then I can give a direct answer for the correct entity in 2026.
Sources
- DrugPatentWatch – Trelstar